Topics

Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs

18:51 EST 31 Jan 2020 | Xconomy

Arcutis Biotherapeutics raised about $159 million from its IPO, offering 1.6 million more shares than anticipated and pricing at the high end of its planned range. The Westlake Village, CA-based biotech sold about 9.4 million of its shares at $17 apiece. Arcutis (NASDAQ: ARQT) shares began trading Friday. The stock price closed at $21.80, up […]

Original Article: Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs

NEXT ARTICLE

More From BioPortfolio on "Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs"

Quick Search

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...